US Patent Issued to Medlmmune on May 19 for "Binding molecules specific for CD73 and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,648, issued on May 19, was assigned to Medlmmune Ltd. (Cambridge, Great Britain).

"Binding molecules specific for CD73 and uses thereof" was invented by Carl Hay (Gaithersburg, Md.), Kris Sachsenmeier (Gaithersburg, Md.), Erin Sult (Gaithersburg, Md.), Qihui Huang (Gaithersburg, Md.), Peter Pavlik (Gaithersburg, Md.), Melissa Damschroder (Gaithersburg, Md.), Li Cheng (Gaithersburg, Md.), Gundo Diedrich (Gaithersburg, Md.), Jonathan Rios-Doria (Gaithersburg, Md.), Scott Hammond (Gaithersburg, Md.), Ralph Minter (Cambridge, Great Britain), Steve Rust (Cambridge, Great Britain), Sandrine Guillard (Cambridge, Great Britain), Robert Hollingsworth (Gaithersburg, Md.), Lutz Jermutus (Camb...